Evidence map›Paper›PMID 40151600›Full record

ArticleEndoscopic ultrasound

Impact of self-expandable metal stent deployment site on stent dysfunction during EUS-guided hepaticogastrostomy.

Takeshi Ogura, Saori Ueno, Atsushi Okuda, Nobu Nishioka, Jun Sakamoto, Masanori Yamada, Masahiro Yamamura, Yuki Uba, Mitsuki Tomita, Nobuhiro Hattori and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Takeshi OguraEndoscopy Center, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Saori Ueno2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Atsushi Okuda2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Nobu Nishioka2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Jun Sakamoto2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Masanori Yamada2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Masahiro Yamamura2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Yuki Uba2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Mitsuki Tomita2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Nobuhiro Hattori2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Junichi Nakamura2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Kimi Bessho2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Hiroki Nishikawa2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Hyperplasia at the distal side of an EUS-guided hepaticogastrostomy (HGS) stent is one of the most frequent causes of stent dysfunction. However, risk factors for hyperplasia during EUS-HGS remain unclear. The aim of the present study was to determine the most appropriate stent site during EUS-HGS to obtain prolonged stent patency. Method: This study included 100 consecutive patients who underwent successful EUS-HGS using a partially covered, self-expandable, metal stent (PCSEMS) between January 2017 and September 2022. The patients were divided into 2 groups according to the distal site of the PCSEMS at the intrahepatic bile duct, the peripheral side group and the central side group. Results: There were 30 patients in the peripheral side group and 70 in the central side group. The diameter of the intrahepatic bile duct at the PCSEMS deployment site was significantly greater in the central side group (mean 7.90 mm) than in the peripheral side group (mean 4.25 mm; Conclusions: In conclusion, the distal site of the PCSEMS deployed at the hepatic hilar site from the confluence between B2 and B3 might play a role in obtaining longer stent patency.

Indexed as

Biliary drainageERCPEUS–guided biliary drainageEUS-guided hepaticogastrostomyEUS-HGS

Identifiers

PMID40151600
PMCPMC11939943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.